News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
181–216
Matches
354
Sources here
10
Companies here
12
Search results Stored financial headlines

Active search

354 matching headlines

Ticker or company: OPTIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

POCI|Precision Optics Corporation Inc|Price:4.310|Chg%:+0.050

This article provides a detailed financial overview and market analysis of Precision Optics Corporation Inc (POCI). It highlights the company's strong fundamentals, high growth potential, and fair valuation within the Healthcare Equipment & Supplies industry. The report also includes current stock prices, key figures, …

POCI main company
Sharemaestro market context Price below Trend Line 52 weeks -11.4% POCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OptimizeRx Corp (OPRX) Financial Health: Profitability & Balance Sheet Analysis

OptimizeRx Corp (OPRX) has a strong financial health score of 7.50, ranking 194th in the Software & IT Services industry. While its financial status is robust, operational efficiency is average, with recent quarterly revenue and net profit showing year-over-year decreases of 9.50% and 77.49% …

OPRX main company
Sharemaestro market context Price above Trend Line 52 weeks -49.4% OPRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OptimizeRx Corp (OPRX) Cash Flow

This article provides a comprehensive cash flow statement for OptimizeRx Corp (OPRX), detailing quarterly and annual data for operating, investing, and financing cash flows. It includes key financial metrics like net income, capital expenditures, and free cash flow, along with year-over-year percentage changes. The …

OPRX main company
Sharemaestro market context Price above Trend Line 52 weeks -49.4% OPRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OptimizeRx Corp (OPRX) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of OptimizeRx Corp's (OPRX) dividend and stock split history. It notes that the company has not distributed any dividends over the past five years. The page displays key financial data for OptimizeRx Corp, including its market cap and P/E …

OPRX main company
Sharemaestro market context Price above Trend Line 52 weeks -49.4% OPRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Optical Cable Corp (OCC) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Optical Cable Corp (OCC), outlining both individual and corporate major shareholders and their respective proportions. It also presents institutional shareholding data over several quarters, showing changes in the number of institutions and shares held. Additionally, the article …

OCC main company
Sharemaestro market context Trend signal active 52 weeks +215.0% · Next-week setup negative 39.8% OCC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Option Care Health, Inc. $OPCH Shares Sold by Gamco Investors INC. ET AL

Gamco Investors INC. ET AL significantly reduced its stake in Option Care Health (NASDAQ:OPCH) during the first quarter by 17.6%, selling over 65,000 shares. Despite this, other institutional investors have recently acquired new positions or increased holdings in the company. Insiders such as Director …

OPCH main company
Sharemaestro market context Price below Trend Line 52 weeks -16.7% OPCH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gabelli Funds LLC Has $8.56 Million Stake in Option Care Health, Inc. $OPCH

Gabelli Funds LLC significantly reduced its stake in Option Care Health (NASDAQ:OPCH) by 36.8% in the first quarter, now holding 318,100 shares worth $8.56 million. Despite this, institutional investors still collectively own a substantial 98.05% of the company. Option Care Health reported strong quarterly …

OPCH main company
Sharemaestro market context Price below Trend Line 52 weeks -16.7% OPCH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Option Care Health Inc (OPCH) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Option Care Health Inc (OPCH), highlighting its major institutional investors and their proportional holdings. It also provides a breakdown of shareholder types, institutional shareholding trends over recent quarters, and lists related ETFs that include OPCH.

OPCH main company
Sharemaestro market context Price below Trend Line 52 weeks -16.7% OPCH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Precision Optics Corporation Inc

This article provides a revenue breakdown for Precision Optics Corporation Inc (POCI) as of April 6, covering its business segments. The company's main revenue streams are Systems Manufacturing, Ross Optical Industries, Engineering Design Services, and Micro Optics Lab. Systems Manufacturing contributes the largest portion …

POCI main company
Sharemaestro market context Price below Trend Line 52 weeks -11.4% POCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OptimizeRx Corp (OPRX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of the shareholder structure for OptimizeRx Corp (OPRX), including major individual and institutional holders and their respective proportions. It also details institutional shareholding trends over recent quarters, changes in specific institutional holdings, and lists related ETFs that include …

OPRX main company
Sharemaestro market context Price above Trend Line 52 weeks -49.4% OPRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OCC|Optical Cable Corp|Price:14.410|Chg%:-1.360

This article provides a detailed company profile for Optical Cable Corp (OCC), a manufacturer of fiber optic and copper data communication solutions. It outlines the company's product offerings, corporate information, key executives, and institutional shareholding data. The content highlights OCC's diverse applications, from enterprise …

OCC main company
Sharemaestro market context Trend signal active 52 weeks +215.0% · Next-week setup negative 39.8% OCC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Option Care Health, Inc. (OPCH) Stock Price, News, Quote & History

This article provides comprehensive financial data for Option Care Health, Inc. (OPCH), including its stock price, historical performance, key financial metrics, and analyst ratings. It details the company's services in home and alternate site infusion therapies and compares its performance against the S&P 500 …

OPCH main company
Sharemaestro market context Price below Trend Line 52 weeks -16.7% OPCH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OPTU|Altice USA Ord Shs Class A|Price:0.806|Chg%:-0.049

Altice USA Ord Shs Class A (OPTU) is currently trading at $0.806, representing a -5.65% change from its previous close. The company's market capitalization is $383.98 million. Analysts have a "Hold" rating for OPTU with a target price of $1.27, suggesting a 41.11% upside.

OPTU main company
Sharemaestro market context Price below Trend Line 52 weeks -61.5% · Next-week setup negative 44.1% OPTU stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OPCH|Option Care Health Inc|Price:21.660|Chg%:+0.580

Option Care Health Inc (OPCH) closed at $21.66, up 2.75%, with a market cap of $3.40 billion. The company shows stable fundamentals and high growth potential, though its stock price is expected to trend down in the medium term. Analysts currently give OPCH a …

OPCH main company
Sharemaestro market context Price below Trend Line 52 weeks -16.7% OPCH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Optical Cable Corp (OCC) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Optical Cable Corp (OCC) as of July 24, 2026. The company's current valuation score is 8.43, placing it 25th out of 54 in its industry. OCC has a P/E ratio of -168.77, with other key metrics like …

OCC main company
Sharemaestro market context Trend signal active 52 weeks +215.0% · Next-week setup negative 39.8% OCC stored weekly price path from 22 Aug 2025 to 14 Aug 2026

POCI|Precision Optics Corporation Inc|Price:4.300|

Precision Optics Corporation Inc (POCI) shows relatively healthy fundamentals and high growth potential, with its valuation considered fairly valued. Institutional ownership is high, and analysts have issued a "Buy" rating with a target price of $8.00. The stock is currently trading sideways, suggesting potential …

POCI main company
Sharemaestro market context Price below Trend Line 52 weeks -11.4% POCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Precision Optics Corporation Inc (POCI) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Precision Optics Corporation Inc (POCI), detailing its current price momentum score, support and resistance levels, and indicator readings. It shows that POCI's stock is currently trading between a resistance level of 5.10 and a support level of …

POCI main company
Sharemaestro market context Price below Trend Line 52 weeks -11.4% POCI stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OptimizeRx Corp (OPRX) Institutional Confidence

OptimizeRx Corp (OPRX) has an institutional shareholding score of 7.00, ranking 139th out of 485 in the Software & IT Services industry. The institutional shareholding proportion recently increased by 8.32% quarter-over-quarter to 82.46%. The largest institutional shareholder is Bill Nygren | OAKMX, holding 1.14M …

OPRX main company
Sharemaestro market context Price above Trend Line 52 weeks -49.4% OPRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OPRX|OptimizeRx Corp|Price:6.240|Chg%:+0.030

OptimizeRx Corp (OPRX) shows strong fundamentals and high growth potential, with its valuation deemed fairly valued within the Software & IT Services industry. Analysts have rated it a "Buy" with a target price of $12.40. While the stock has seen strong market performance, technical …

OPRX main company
Sharemaestro market context Price above Trend Line 52 weeks -49.4% OPRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Syntec Optics (Nasdaq: OPTX) Included in Russell 3000® Index

ROCHESTER, NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (NASDAQ: OPTX) (“Syntec Optics”), a premier provider of deep tech solutions for defense and space modernization, today announced that it has been included in the Russell 3000® Index. The final, fully …

OPTX main company
Sharemaestro market context Price above Trend Line 52 weeks +468.4% OPTX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OptimizeRx appoints Sarah Bast as chief marketing officer By Investing.com

OptimizeRx Corp. (NASDAQ:OPRX) announced the appointment of Sarah Bast as Chief Marketing Officer. Bast brings over 20 years of pharmaceutical marketing experience, having previously served as Executive Vice President at Publicis Health Media and guided marketing strategy for major life sciences companies. In her …

OPRX main company
Sharemaestro market context Price above Trend Line 52 weeks -49.4% OPRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer

WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients at key decision moments, today announced the appointment of Sarah Bast …

OPRX main company
Sharemaestro market context Price above Trend Line 52 weeks -49.4% OPRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Sarah Bast Brings More Than Two Decades of Pharma Marketing to OptimizeRx

OptimizeRx (Nasdaq: OPRX) has appointed Sarah Bast as its new Chief Marketing Officer, effective July 23, 2026. Bast brings over two decades of experience in pharmaceutical marketing, specializing in point of care media strategy, analytics, and optimization. In her new role, she will lead …

OPRX main company
Sharemaestro market context Price above Trend Line 52 weeks -49.4% OPRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Royce & Associates (OPRX) discloses 1.09M-share passive stake in OptimizeRx

Royce & Associates, LP has disclosed a passive stake of 1,089,398 shares in OptimizeRx Corp (OPRX), representing 5.81% of the company's common stock as of June 30, 2026. Royce & Associates, an indirect majority-owned subsidiary of Franklin Resources, Inc., holds this position for its …

OPRX main company
Sharemaestro market context Price above Trend Line 52 weeks -49.4% OPRX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Option Care Health (OPCH) Expected to Announce Quarterly Earnings on Wednesday

Option Care Health (OPCH) is set to announce its Q2 2026 earnings before market open on Wednesday, July 29th, with analysts forecasting earnings of $0.42 per share and revenue of $1.4181 billion. The company surpassed EPS expectations in the previous quarter, reporting $0.40 against …

OPCH main company
Sharemaestro market context Price below Trend Line 52 weeks -16.7% OPCH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Fifth Third Bancorp Grows Holdings in Option Care Health, Inc. $OPCH

Fifth Third Bancorp significantly increased its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 3,855.4% in the first quarter, now owning 92,082 shares valued at $2.479 million. Other institutional investors have also recently adjusted their positions. The article also details recent insider buying activity …

OPCH main company
Sharemaestro market context Price below Trend Line 52 weeks -16.7% OPCH stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context